Gilead’s Veklury Becomes the First FDA-approved COVID-19 Treatment for Infants
Summary : The first treatment for COVID-19 in young children has been approved by the US Food and Drug Administration. In this…
Summary : The first treatment for COVID-19 in young children has been approved by the US Food and Drug Administration. In this…
Summary : Piramal Enterprises said in a regulatory filing on Wednesday that its subsidiary Piramal Pharma Ltd has signed into a deal…
Summary : The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies, to have 100 per cent holding in…
Summary Dr Reddy’s Laboratories, an Indian generic pharmaceutical company, has agreed to pay $61 million to Novartis AG for the cardiovascular brand…
Summary : AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson’s disease and other movement…
Summary : Five Prime’s lead asset, Bemarituzumab, is a first-in-class, Phase 3 ready anti-FGFR2b antibody with positive data from a randomized, placebo-controlled…
Synopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total consideration of up to $525 million, including…
Synopsis : GlaxoSmithKline plc and Sierra Oncology, Inc have announced that GSK will acquire Sierra Oncology, a California-based late-stage biopharmaceutical company focused…
Summary : The Australian Pesticides and Veterinary Administration (APVMA) has proposed approval of Bayer CropScience Pvt Ltd’s fungicide Xivana Prime 20 SC,…
Summary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the…